Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Pittsburgh
Region Stockholm
Beth Israel Deaconess Medical Center
Northwestern University
Hospital Clinico Universitario de Santiago
Abivax S.A.
Assistance Publique Hopitaux De Marseille
Nordsjaellands Hospital
Odense University Hospital
AbbVie
Helse Møre og Romsdal HF